Literature DB >> 17339114

Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore.

Gianfranco Balboni1, Valentina Onnis, Cenzo Congiu, Margherita Zotti, Yusuke Sasaki, Akihiro Ambo, Sharon D Bryant, Yunden Jinsmaa, Lawrence H Lazarus, Ilaria Lazzari, Claudio Trapella, Severo Salvadori.   

Abstract

A wide range of activities are induced by Lys when introduced at C-terminus of the delta-opioid Dmt-Tic pharmacophore through the alpha-amine group, including: improved delta-antagonism, mu-agonism and mu-antagonism. Here we report the synthesis of a new series of compounds with the general formula H-Dmt-Tic-NH-(CH(2))(4)-CH(R)-R' (R=-NH(2), -NH-Ac, -NH-Z; R'=CO-NH-Ph, -CO-NH-CH(2)-Ph, -Bid) in which Lys is linked to Dmt-Tic through its side-chain amine group. All new compounds (1-9) displayed potent and selective delta-antagonism (MVD, pA(2)=7.81-8.27), which was independent of the functionalized alpha-amine and carboxylic groups of C-terminal Lys. This behaviour suggests a direct application as a prototype intermediate, such as Boc-Dmt-Tic-epsilon-Lys(Z)-OMe, which could be successfully applied in the synthesis (after Z or methyl ester removal) of unique designed multiple ligands containing the pharmacophore of the quintessential delta-antagonist Dmt-Tic and another opioid or biologically active non-opioid ligand.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339114      PMCID: PMC2377021          DOI: 10.1016/j.bmc.2007.02.039

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  29 in total

1.  Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.

Authors:  Gianfranco Balboni; Severo Salvadori; Remo Guerrini; Lucia Negri; Elisa Giannini; Sharon D Bryant; Yunden Jinsmaa; Lawrence H Lazarus
Journal:  J Med Chem       Date:  2004-07-29       Impact factor: 7.446

2.  Molecular mechanism of opioid receptor selection.

Authors:  R Schwyzer
Journal:  Biochemistry       Date:  1986-10-07       Impact factor: 3.162

3.  Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity.

Authors:  L H Lazarus; S Salvadori; M Attila; P Grieco; D M Bundy; W E Wilson; R Tomatis
Journal:  Peptides       Date:  1993 Jan-Feb       Impact factor: 3.750

4.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  Dermorphin gene sequence peptide with high affinity and selectivity for delta-opioid receptors.

Authors:  L H Lazarus; W E Wilson; R de Castiglione; A Guglietta
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

6.  Endomorphin 2 analogues containing Dmp residue as an aromatic amino acid surrogate with high mu-opioid receptor affinity and selectivity.

Authors:  Yusuke Sasaki; Ai Sasaki; Hideko Niizuma; Harumi Goto; Akihiro Ambo
Journal:  Bioorg Med Chem       Date:  2003-03-06       Impact factor: 3.641

7.  Function of negative charge in the "address domain" of deltorphins.

Authors:  L H Lazarus; S Salvadori; V Santagada; R Tomatis; W E Wilson
Journal:  J Med Chem       Date:  1991-04       Impact factor: 7.446

8.  Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).

Authors:  H W Kosterlitz; A J Watt
Journal:  Br J Pharmacol Chemother       Date:  1968-06

9.  Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.

Authors:  S Salvadori; M Attila; G Balboni; C Bianchi; S D Bryant; O Crescenzi; R Guerrini; D Picone; T Tancredi; P A Temussi
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

Review 10.  Dmt and opioid peptides: a potent alliance.

Authors:  Sharon D Bryant; Yunden Jinsmaa; Severo Salvadori; Yoshio Okada; Lawrence H Lazarus
Journal:  Biopolymers       Date:  2003       Impact factor: 2.505

View more
  4 in total

1.  A new opioid designed multiple ligand derived from the micro opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic.

Authors:  Severo Salvadori; Claudio Trapella; Stella Fiorini; Lucia Negri; Roberta Lattanzi; Sharon D Bryant; Yunden Jinsmaa; Lawrence H Lazarus; Gianfranco Balboni
Journal:  Bioorg Med Chem       Date:  2007-08-29       Impact factor: 3.641

2.  Inhibition of the development of morphine tolerance by a potent dual mu-delta-opioid antagonist, H-Dmt-Tic-Lys-NH-CH2-Ph.

Authors:  Yunden Jinsmaa; Ewa D Marczak; Gianfranco Balboni; Severo Salvadori; Lawrence H Lazarus
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

3.  Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.

Authors:  Eun Kyoung Ryu; Zhanhong Wu; Kai Chen; Lawrence H Lazarus; Ewa D Marczak; Yusuke Sasaki; Akihiro Ambo; Severo Salvadori; Chuancheng Ren; Heng Zhao; Gianfranco Balboni; Xiaoyuan Chen
Journal:  J Med Chem       Date:  2008-03-01       Impact factor: 7.446

4.  Multifunctional Enkephalin Analogs with a New Biological Profile: MOR/DOR Agonism and KOR Antagonism.

Authors:  Yeon Sun Lee; Michael Remesic; Cyf Ramos-Colon; Zhijun Wu; Justin LaVigne; Gabriella Molnar; Dagmara Tymecka; Aleksandra Misicka; John M Streicher; Victor J Hruby; Frank Porreca
Journal:  Biomedicines       Date:  2021-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.